InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

BRNS Stock Earnings: Barinthus Biotherapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

BRNS stock results show that Barinthus Biotherapeutics missed analyst estimates for earnings per share the second quarter of 2024.

IRON Stock Earnings: Disc Medicine Beats EPS for Q2 2024

By InvestorPlace Earnings

IRON stock results show that Disc Medicine beat analyst estimates for earnings per share the second quarter of 2024.

PHAT Stock Earnings: Phathom Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

PHAT stock results show that Phathom Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

RLYB Stock Earnings: Rallybio Misses EPS for Q2 2024

By InvestorPlace Earnings

RLYB stock results show that Rallybio missed analyst estimates for earnings per share the second quarter of 2024.

PEPG Stock Earnings: PepGen Misses EPS for Q2 2024

By InvestorPlace Earnings

PEPG stock results show that PepGen missed analyst estimates for earnings per share the second quarter of 2024.

Load More